TransMedics shareholders elect all 8 director nominees, approve exec comp and auditor at 2025 annual meeting

TransMedics Group, Inc.

All 8 director nominees (Hassanein, Tobin, Basile, Gunderson, Kania, Lovell, Raines, Weill) elected with 19.5M-21.5M votes each.
Non-binding advisory vote on named executive officer compensation passed: 20.9M for, 756K against, 54.5K abstain.
Ratification of PricewaterhouseCoopers as independent auditor for FY2025 approved: 24.4M for, 2.1M against, 53K abstain.
Broker non-votes of 4.9M on director election and say-on-pay proposals.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.